ArticleClinical drug investigation2016

Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDegLira than Either Insulin Degludec or Liraglutide Given Alone.

Tina Vilsbøll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.